about
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for au...
Read More
3.95
-0.03
(-0.75%)
880.5K
XNAS Volume
XNAS 07 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for Savara Inc is on 12 Nov 2025 for the purpose of Savara Inc Third Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Savara Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..